Nearly one in four Americans experienced some kind of mental illness in the last year, according to a new report from Mental Health America. The “2025 State of Mental Health in America” report was ...

Fewer than 40% of Medicare beneficiaries with opioid-use disorders receive proper care, study finds In 2022, 52,000 Medicare beneficiaries experienced an opioid overdose, according to the Centers for ...

About 66% of people reported that they, or a family member, had experienced substance abuse Getty The drug crisis is hitting home for the majority of adults in the U.S. According to the latest ...

(AP) - Prescriptions for ADHD treatments surged among adults during the COVID-19 pandemic, helping to fuel lingering shortages that frustrate parents and doctors. New prescriptions for stimulants used ...

Thanks to grant funding from the Montana Opioid Abatement Trust, an Adult Drug Treatment Court is coming to Flathead County ...

Elaine Quijano reports on a program called Generation S.O.S., which brings in young adults who have struggled with mental ...

This story is republished with the permission of The Press Times part of the NEW (Northeast Wisconsin) News Lab's fourth series, "Families Matter," covering issues important to families in the region.

The Food and Drug Administration (FDA) has approved Koselugo ® (selumetinib) for adults with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN). Previously, ...